GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anti-Microbial Savior BioteQ Co 6864.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

37.50

+10.46%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 706,000

FY2018FY2025

Net income

−TWD 93.6m

FY2018FY2025

Free cash flow

−TWD 84.6m

FY2018FY2025

Shareholders' equity

TWD 510.5m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueTWD 706,000TWD 612,000TWD 728,000TWD 2.7mTWD 88,000TWD 73,000——
Research and developmentTWD 60.9mTWD 53.5mTWD 45.1mTWD 31.6mTWD 21.2mTWD 15.8mTWD 8.9mTWD 607,000
Operating income−TWD 96.0m−TWD 76.5m−TWD 59.9m−TWD 43.4m−TWD 28.3m−TWD 18.0m−TWD 10.3m−TWD 754,000
Net income−TWD 93.6m−TWD 74.5m−TWD 51.8m−TWD 31.7m−TWD 22.4m−TWD 14.0m−TWD 9.0m−TWD 744,000
Diluted earnings per share-2.84-2.27-1.57-0.96-0.68-0.56-0.36-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsTWD 520.4mTWD 248.2mTWD 128.0mTWD 182.0mTWD 221.2mTWD 142.7mTWD 75.9mTWD 79.4m
Cash and short-term investments—————TWD 92.4mTWD 30.3mTWD 78.2m
Total liabilitiesTWD 9.9mTWD 10.9mTWD 7.0mTWD 9.8mTWD 17.2mTWD 6.4mTWD 5.7mTWD 148,000
Debt————TWD 9.2mTWD 4.1mTWD 5.0m—
Shareholders' equityTWD 510.5mTWD 237.3mTWD 121.1mTWD 172.2mTWD 203.9mTWD 136.3mTWD 70.3mTWD 79.3m
Shares outstanding33m33m33m33m33m25m25m25m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−TWD 77.7m−TWD 64.1m−TWD 48.3m−TWD 30.7m−TWD 20.1m−TWD 9.4m−TWD 8.2m−TWD 609,000
Capital spending−TWD 6.8m−TWD 8.4m−TWD 1.5m−TWD 7.7m−TWD 3.3m−TWD 7.9m−TWD 38.3m—
Free cash flow−TWD 84.6m−TWD 72.5m−TWD 49.8m−TWD 38.4m−TWD 23.4m−TWD 17.3m−TWD 46.4m−TWD 609,000

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 290,000TWD 267,000TWD 345,000TWD 193,000TWD 535,000TWD 1.3mTWD 1.4mTWD 88,000
Operating income−TWD 47.2m−TWD 44.2m−TWD 32.2m−TWD 32.3m−TWD 27.6m−TWD 24.5m−TWD 18.9m−TWD 16.0m
Net income−TWD 46.2m−TWD 43.1m−TWD 31.4m−TWD 31.2m−TWD 20.5m−TWD 19.1m−TWD 12.6m−TWD 12.9m
Diluted earnings per share-1.40-1.32-1.08-1.23-0.82-0.76-0.50-1.02
Total assetsTWD 201.1mTWD 248.2mTWD 174.6mTWD 128.0mTWD 158.3mTWD 182.0mTWD 209.2mTWD 221.2m
Cash and short-term investments———TWD 78.4mTWD 104.5mTWD 131.1mTWD 162.8mTWD 166.6m
Debt————TWD 522,000TWD 1.4mTWD 10.6mTWD 11.8m
Shareholders' equityTWD 192.8mTWD 237.3mTWD 168.1mTWD 121.1mTWD 152.1mTWD 172.2mTWD 191.3mTWD 203.9m

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Operating margin-13254.4%-12170.8%-7795.2%-1472.9%-32164.8%
Net margin-13257.4%-12176.0%-7112.9%-1176.8%-25398.9%
Return on equity-18.3%-31.4%-42.8%-18.4%-11.0%
Return on assets-18.0%-30.0%-40.4%-17.4%-10.1%
Free cash flow yield-5.0%-4.0%———
Revenue growth15.4%-15.9%-73.0%2964.8%—
Earnings growth25.6%43.9%63.2%42.0%—
Current ratio47.84x19.01x11.94x15.94x31.39x
Debt to equity——0.00x0.00x0.04x
Equity ratio98.1%95.6%94.5%94.6%92.2%
Interest coverage-4456.00x-2327.66x-1351.17x-484.45x-318.03x
R&D as a share of sales8630.9%8748.4%6197.1%1172.9%24108.0%
Buybacks as a share of market value-0.5%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-36.0%57.4%—
Operating income30.3%39.8%—
Net income43.4%46.3%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-13085.1%-5813.6%-6567.0%—
Net margin-12755.2%-5305.4%-5871.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-30.3-26.8-16.0-31.8-84.7
Price to sales———373.7—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.